|Positive WB detected in||HeLa cells, mouse testis tissue|
|Positive IP detected in||mouse testis tissue|
|Western Blot (WB)||WB : 1:500-1:2000|
|Immunoprecipitation (IP)||IP : 0.5-4.0 ug for IP and 1:500-1:2000 for WB|
|Sample-dependent, check data in validation data gallery|
14961-1-AP targets RAD51 in WB, IP,ELISA applications and shows reactivity with human, mouse samples.
|Tested Reactivity||human, mouse|
|Cited Reactivity||human, mouse|
|Host / Isotype||Rabbit / IgG|
|Immunogen||RAD51 fusion protein Ag6823|
|Full Name||RAD51 homolog (RecA homolog, E. coli) (S. cerevisiae)|
|Calculated molecular weight||37 kDa|
|Observed molecular weight||37 kDa|
|GenBank accession number||BC001459|
|Gene ID (NCBI)||5888|
|Purification Method||Antigen affinity purification|
|Storage Buffer||PBS with 0.02% sodium azide and 50% glycerol pH 7.3.|
|Storage Conditions||Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.|
RAD51 plays a critical role in the maintenance of genomic integrity by functioning in the repair of DNA double-strand breaks. It mediates homologous pairing and strand exchange in recombinatory structures known as RAD51foci in the nucleus. It also can bind to single and double stranded DNA and exhibits DNA-dependent ATPase activity. In addition, it has a role in regulating mitochondrial DNA copy number under conditions of oxidative stress in the presence of RAD51C and XRCC3.
Arch Biochem Biophys
MiR-34s negatively regulate homologous recombination through targeting RAD51.
J Cell Mol Med
RDM1 promotes critical processes in breast cancer tumorigenesis.
J Cell Mol Med
Berberine attenuates XRCC1-mediated base excision repair and sensitizes breast cancer cells to the chemotherapeutic drugs.
Triptolide interferes with XRCC1/PARP1-mediated DNA repair and confers sensitization of triple-negative breast cancer cells to cisplatin.
Inhibition of survivin induces spindle disorganization, chromosome misalignment, and DNA damage during mouse embryo development.
J Exp Clin Cancer Res
UBE2T-regulated H2AX monoubiquitination induces hepatocellular carcinoma radioresistance by facilitating CHK1 activation.